Canine urothelial carcinoma: genomically aberrant and comparatively relevant

Chromosome Research

Volumn 23, Issue 2, 2015, Pages 311-331

  Shapiro, S G ^a   Raghunath, S ^a,b   Williams, C ^a   Motsinger Reif, A A ^a   Cullen, J M ^a   Liu, T ^b   Albertson, D ^b   Ruvolo, M ^c   Bergstrom Lucas, A ^c   Jin, J ^c   Knapp, D W ^d   Schiffman, J D ^b   Breen, M ^a,e  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c AGILENT TECHNOLOGIES   (United States)

^d PURDUE UNIVERSITY   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Array comparative genomic hybridization; Canine; Chromosome aberration; Comparative oncology; Cytogenetics; Transitional cell carcinoma; Urothelial carcinoma

Indexed keywords

ANIMAL; BIOLOGY; BIOPSY; CARCINOMA; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DOG; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENOMICS; HUMAN; MALE; PROCEDURES; URINARY TRACT TUMOR; VETERINARY;

ANIMALS; BIOPSY; CARCINOMA; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTATIONAL BIOLOGY; DNA COPY NUMBER VARIATIONS; DOGS; FEMALE; GENETIC LOCI; GENOMICS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; UROLOGIC NEOPLASMS;

EID: 84939946307     PISSN: 09673849     EISSN: 15736849     Source Type: Journal    
DOI: 10.1007/s10577-015-9471-y     Document Type: Article

References (51)

1. American Cancer Society (2014) Cancer facts and figures 2014. Society AC, Atlanta
2. American Joint Committee on Cancer (2002) Urinary bladder. In: Greene F, Page D, Fleming I et al (eds) Cancer staging manual. Springer-Verlag, New York, pp 335–338
3. Anderson W, Dunham B, King J et al (1989) Presumptive subcutaneous transplation of a urinary bladder transitional cell carcinoma of the urinary bladder in a dog. Cornell Vet 79:263–266
4. Angstadt AY, Motsinger-Reif A, Thomas R et al (2011) Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart. Genes Chromosom Cancer 50(11):859–874
5. Angstadt AY, Thayanithy V, Subramanian S, Modiano JF, Breen M (2012) A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations. Cancer Genet 205(11):572–587
6. Bansal N, Gupta A, Sankhwar SN, Mahdi AA (2014) Low- and high-grade bladder cancer appraisal via serum-based proteomics approach. Clin Chim Acta 436:97–103
7. Bhatlekar S, Fields JZ, Boman BM (2014) HOX genes and their role in the development of human cancers. J Mol Med (1432–1440 (Electronic))
8. Cai H, Kumar N, Bagheri H, von Mering C, Robinson M, Baudis M (2014) Chromothripsis-like patterns are recurring but heterogenously distributed features in a survery of 22,347 cancer genome screens. BMC Genomics 15:82
9. Calin GA, Dumitru CS et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci 101(9):2999–3004
10. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C (2010) Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 28(4):401–408
11. Chekaluk Y, Wu CL, Rosenberg J et al (2013) Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value. PLoS One 8(4):e60927
12. Chen R, Feng C, Xu Y (2011) Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression. J Int Med Res 39(2):533–540
13. Development Team R (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
14. Dhawan D, Ramos-Vara JA, Stewart JC, Zheng R, Knapp DW (2009) Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer. Urol Oncol 27(3):284–292
15. Dobson JM (2013) Breed-predispositions to cancer in pedigree dogs. ISRN Veterinary Science 2013
16. Ebbing J, Mathia S, Seibert F et al (2013) Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder. World J Urol 1–8
17. Eliseeva IA, Lyabin DN, Ovchinnikov LP (2013) Poly(A)-binding proteins: structure, domain organization, and activity regulation. Biochemistry Moscow 78(13):1377–1391
18. Fadl-Elmula I (2005) Chromosomal changes in uroepithelial carcinomas. Cell Chromosom 4:1
19. Goebell PJ, Knowles MA (2010) Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol Oncol 28(4):409–428
20. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH (2009) The WEKA Data Mining Software: an update. SIGKDD Explorations 11(1)
21. Hedan B, Thomas R, Motsinger-Reif A et al (2011) Molecular cytogenetic characterization of canine histiocytic sarcoma: a spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior. BMC Cancer (in revision)
22. Heidenblad M, Lindgren D, Jonson T et al (2008) Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors. BMC Med Genomics 1:3
23. Hosseini SA, Horton S, Saldivar JC et al (2013) Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability. Genes Chromosom Cancer 52(11):1017–1029
24. Karolchik D, Hinrichs AS, Furey TS et al (2004) The UCSC Table Browser data retrieval tool. Nucleic Acids Res 32(suppl 1):D493–D496
25. Kim WJ, Kim SK, Jeong P et al (2011) A four-gene signature predicts disease progression in muscle invasive bladder cancer. Mol Med 17(5–6):478–485
26. Kim WT, Kim J, Yan C et al (2014) S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy. Ann Oncol 25(5):974–979
27. Knapp DW, Glickman NW, Denicola DB, Bonney PL, Lin TL, Glickman LT (2000) Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer. Urol Oncol 5(2):47–59
28. Knapp D, Ramos-Vara J, Moore G, Dhawan D, Bonney P, Young K (2014) Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. ILAR J 55(1):100–118
29. Langbein S, Szakacs O, Wilhelm M et al (2002) Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Investig 82(5):639–643
30. Ma K, Qiu L, Mrasek K et al (2012) Common fragile sites: genomic hotspots of DNA damage and carcinogenesis. Int J Mol Sci 13(9):11974–11999
31. Mutsaers AJ, Widmer WR, Knapp DW (2003) Canine transitional cell carcinoma. J Vet Intern Med 17(2):136–144
32. Oliveira PA, Arantes-Rodrigues R, Vasconcelos-Nóbrega C (2014) Animal models of urinary bladder cancer and their application to novel drug discovery. Expert Opin Drug Discov 9(5):485–503
33. Panani A, Roussos C (2006) Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma. Anticancer Res 26(1):319–323
34. Poorman K, Borst L, Moroff S et al (2014) Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization. Chromosom Res (in press)
35. Prazeres H, Torres J, Rodrigues F, Pinto M (2011) Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular envrionemnt of thyroid cancer cells. Oncogene 30:1302–1317
36. Quinlan AR, Hall IM (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26(6):841–842
37. Richards R (2001) Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet 17(6):339–345
38. Richter J, Beffa L, Wagner U et al (1998) Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 153(5):1615–1621
39. Sahrief Y, Reich C, Bonar R (1980) Polyploidy in mammalian urothelial cells. Urol Res 8:153–161
40. Schulz W (2006) Understanding urothelial carcinoma through cancer pathways. Int J Cancer 119:1513–1518
41. Shearin AL, Ostrander EA (2010) Leading the way: canine models of genomics and disease. Dis Model Mech 3(1–2):27–34
42. Simoneau M, LaRue H, Aboulkassim T, Meyer F, Moore L, Fradet Y (2000) Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Oncogene 19(54):6317–6323
43. Stephens P, Greenman C, Fu B, Yang F et al (2011) Massive genomic rearrangement required in a single catastrophic event during cancer development. Cell 144(1):27–40
44. The Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507(7492):315–322
45. Thomas PD, Campbell MJ, Kejariwal A et al (2003a) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13(9):2129–2141
46. Thomas PD, Kejariwal A, Campbell MJ et al (2003b) PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 31(1):334–341
47. Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M (2003c) Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer 89(8):1530–1537
48. Thomas R, Seiser EL, Motsinger-Reif A et al (2011) Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas. Leuk Lymphoma 52(7):1321–1335
49. Thomas R, Borst L, Rotroff D et al (2014) Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma. Chromosom Res 1–15
50. van Duin M, van Marion R, Vissers K et al (2005) High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. Genes Chromosom Cancer 44(4):438–449
51. Xiao H, Li H, Yu G et al (2014) MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer. Oncol Rep 31(4):1832–1838